Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
98,567,360
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
26,983,278
-
Shares change
-
-3,042,037
-
Total reported value, excl. options
-
$94,705,000
-
Value change
-
-$19,319,881
-
Number of buys
-
31
-
Number of sells
-
-42
-
Price
-
$3.51
Significant Holders of ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) as of Q1 2022
81 filings reported holding SPRY - ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q1 2022.
ARS Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (SPRY) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,983,278 shares
of 98,567,360 outstanding shares and own 27.4% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (8,740,887 shares), FMR LLC (3,793,041 shares), WASATCH ADVISORS INC (2,974,228 shares), Nextech Invest AG (1,910,029 shares), BlackRock Inc. (1,607,500 shares), Nantahala Capital Management, LLC (913,597 shares), VANGUARD GROUP INC (823,296 shares), RENAISSANCE TECHNOLOGIES LLC (670,542 shares), TWO SIGMA INVESTMENTS, LP (401,176 shares), and MORGAN STANLEY (385,947 shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.